Acute Brucellosis Presenting as an Autoimmune Hemolytic Anemia

Table 1

Clinical and demographic characteristics of reported hemolytic complications in brucellosis.

First author; year of publication	Country	Number of cases	Age/gender	Hematological disease	Treatment
Kiki et al. [6]; 2008	Turkey	1	19 yr, female	TTP	Doxycycline, rifampicin, plasma exchange
Wehbe and Moore [7]; 2008	United States	1	34 yr, female	AIHA	No immunosuppressant
Sari et al. [10]; 2008	Turkey	1	26 yr, female	AIHA	Corticosteroids
Bourantas et al. [8]; 2010	Greece	1	79 yr, female	AIHA	Corticosteroids, rituximab
Apa et al. [11]; 2013	Turkey	1	5-month infant	AIHA	Rifampicin, trimethoprim/sulfamethoxazole Blood transfusion, corticosteroids
Eskazan et al. [9]; 2014	Turkey	2	72 yr, male; 50 yr, female	AIHA	Doxycycline, rifampicin, corticosteroids
Tunccan et al. [4]; 2014	Turkey	1	75 yr, male	ITP	Doxycycline, rifampicin, corticosteroids
Makis et al. [3]; 2017	Greece	1	5.5 yr female	ITP	Rifampicin, trimethoprim/sulfamethoxazole (TMP/SMX), IV IG

AIHA = autoimmune hemolytic anemia; TTP = thrombotic thrombocytopenic purpura; ITP = immune thrombocytopenic purpura.